(Q43037796)

English

Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection: decision-tree analysis

scientific article published on 17 June 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection: decision-tree analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

pegylated interferon

1 reference

based on heuristic

inferred from title

3

object named as

Naoya Sakamoto

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

11

object named as

Namiki Izumi

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

author name string

Naoki Hiramatsu

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Masayuki Kurosaki

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Manabu Iwasaki

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Minoru Sakamoto

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Yoshiyuki Suzuki

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Fuminaka Sugauchi

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Akihiro Tamori

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sei Kakinnuma

9

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Kentaro Matsuura

10

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

17 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

46

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1111-1119

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Diagnosis, management, and treatment of hepatitis C

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0412-Z

21 January 2018

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0412-Z

21 January 2018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0412-Z

21 January 2018

Factors contributing to ribavirin-induced anemia

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0412-Z

21 January 2018

Factors contributing to ribavirin dose reduction due to anemia during interferon alfa2b and ribavirin combination therapy for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0412-Z

21 January 2018

Factors influencing ribavirin-induced hemolysis

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0412-Z

21 January 2018

Population pharmacokinetic and pharmacodynamic analysis of ribavirin in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0412-Z

21 January 2018

Evidence that plasma concentration rather than dose per kilogram body weight predicts ribavirin-induced anaemia

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0412-Z

21 January 2018

Ribavirin pharmacokinetics in renal and liver transplant patients: evidence that it depends on renal function

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0412-Z

21 January 2018

Early decline of hemoglobin can predict progression of hemolytic anemia during pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0412-Z

21 January 2018

Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0412-Z

21 January 2018

Improved detection of prostate cancer using classification and regression tree analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0412-Z

21 January 2018

Novel statistical classification model of type 2 diabetes mellitus patients for tailor-made prevention using data mining algorithm

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0412-Z

21 January 2018

A long-term analysis of 1018 patients with melanoma by classic Cox regression and tree-structured survival analysis at a major referral center: Implications on the future of cancer staging.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0412-Z

21 January 2018

Prognostic groups in colorectal carcinoma patients based on tumor cell proliferation and classification and regression tree (CART) survival analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0412-Z

21 January 2018

Phosphorus ans an early predictive factor in patients with acute liver failure

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0412-Z

21 January 2018

A predictive model of response to peginterferon ribavirin in chronic hepatitis C using classification and regression tree analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0412-Z

21 January 2018

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0412-Z

21 January 2018

A comparison of estimated proportional hazards models and regression trees.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0412-Z

21 January 2018

Ribavirin dose reduction raises relapse rate dose-dependently in genotype 1 patients with hepatitis C responding to pegylated interferon alpha-2b plus ribavirin

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0412-Z

21 January 2018

ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0412-Z

21 January 2018

Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia and decrease the need for ribavirin dose reduction

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0412-Z

21 January 2018

ITPA polymorphism affects ribavirin-induced anemia and outcomes of therapy--a genome-wide study of Japanese HCV virus patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0412-Z

21 January 2018

Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21681410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A predictive model of rectal tumor response to preoperative radiotherapy using classification and regression tree methods

1 reference

https://pubmed.ncbi.nlm.nih.gov/21681410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/21681410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A review of tree-based prognostic models

1 reference

https://pubmed.ncbi.nlm.nih.gov/21681410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sequences in the interferon sensitivity-determining region and core region of hepatitis C virus impact pretreatment prediction of response to PEG-interferon plus ribavirin: data mining analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21681410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society

1 reference

https://pubmed.ncbi.nlm.nih.gov/21681410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00535-011-0412-Z

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43037796&oldid=1978291491"